Next Generation News and Research

RSS

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

CTI BioPharma Corp. and Baxter International Inc. today announced positive top-line results for the primary endpoint from PERSIST-1, the randomized, controlled Phase 3 registration clinical trial examining pacritinib, a next generation oral JAK2/FLT3 multikinase inhibitor, for the treatment of patients with primary or secondary myelofibrosis.

From Baxter International Inc. 9 Mar 2015

Covalon announces introduction of new MediClear product line to reduce surgical site infections

Covalon Technologies Ltd, an advanced medical technologies company, today announced the introduction of its new MediClear product line designed to significantly improve patient compliance with efforts to reduce surgical site infections (SSI).

8 Mar 2015

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome.

6 Mar 2015

Medical Diagnostic Laboratories now offers new HPV tests

Medical Diagnostic Laboratories, L.L.C., a CLIA-certified, CAP-accredited laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announces that it is now offering new Human Papillomavirus (HPV) testing which utilizes cutting edge technology, including next- generation DNA sequencing platforms.

5 Mar 2015

Pediatric Cancer Genome Project identifies genetic basis of three pediatric melanoma subtypes

The St. Jude Children's Research Hospital—Washington University Pediatric Cancer Genome Project found that melanoma in some adolescent and adult patients involves many of the same genetic alterations and would likely respond to the same therapy.

5 Mar 2015

New approach could dramatically increase survival rate of cancer patients

Michail Sitkovsky, an immunophysiology expert at Northeastern University, and his research colleagues have made a breakthrough discovery in cancer treatment. The new approach, some 30 years in the making, could dramatically increase the survival rate of patients with cancer, which kills some 8 million people each year.

5 Mar 2015

Oxytocin may be a potential therapeutic target for improving social function in psychiatric disorders

Researchers at the Yerkes National Primate Research Center, Emory University, have shown inducing the release of brain oxytocin may be a viable therapeutic option for enhancing social function in psychiatric disorders, including autism spectrum disorders and schizophrenia.

4 Mar 2015

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

4 Mar 2015

Raising sale age for tobacco products to 21 may prevent adolescents from taking up smoking

Raising the minimum age to buy cigarettes to 21 would save lives by preventing adolescents from ever taking up smoking, a new report suggests.

4 Mar 2015

VWR, New England Biolabs expand distribution agreement

VWR, a leading, independent provider of laboratory products, services and solutions, announced today the expansion of its distribution agreement with New England Biolabs, Inc.

From New England Biolabs 3 Mar 2015

Damon Runyon holds fourth annual Accelerating Cancer Cures Research Symposium

Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.

3 Mar 2015

Chrono Therapeutics gets support to develop SmartStop device for smoking cessation

Chrono Therapeutics, a pioneer in digital drug products, today announced an investment by Rock Health, the leading seed fund in digital health, to support the advancement of Chrono's SmartStop programmable transdermal drug delivery system and real-time behavioral support program for smoking cessation.

3 Mar 2015

Tian Ge, Xi He collaborate to develop new mobile health management platform

Tian Ge Interactive Holdings Limited, the largest "many-to-many" live social communities platform in China, announced that the Company has agreed to invest approximately RMB24 million (~USD$3.8 million) in exchange for approximately 34.47% equity interest in Hangzhou Xi He Technology Co., Ltd., a market leader in providing health management software to hospitals and physical check-up clinics in China, on a fully-diluted basis.

3 Mar 2015

Caltech researchers reveal new information that could help fight against hookworms

Tiny parasitic hookworms infect nearly half a billion people worldwide--almost exclusively in developing countries--causing health problems ranging from gastrointestinal issues to cognitive impairment and stunted growth in children. By sequencing and analyzing the genome of one particular hookworm species, Caltech researchers have uncovered new information that could aid the fight against these parasites.

3 Mar 2015

Scientists sequence genome of hookworm

In an advance that may potentially lead to new treatments for parasitic hookworms, scientists at the University of Massachusetts Medical School and Cornell University have sequenced the genome of the hookworm, Ancylostoma ceylanicum.

3 Mar 2015

Revolutionary Oral-B Bluetooth-enabled toothbrush, App launched at Mobile World Congress 2015

Oral-B, the worldwide leader in oral care, unveils improvements to its App that connects to its highest performing toothbrushes, by creating seamless brushing routines and allowing for expanded professional guidance, at the 2015 annual GSMA Mobile World Congress meeting in Barcelona, Spain.

2 Mar 2015

UC San Diego Health System's Movement Disorder Center joins NPF Center of Excellence network

The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This designation is the highest recognition offered by NPF to a Parkinson's specialty clinic. It represents the consensus of leaders in the field that the UC San Diego program is among the world's leading centers for Parkinson's research, outreach and care.

27 Feb 2015

Metrohm USA announces 2015 Young Chemist Award winner

Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades.

26 Feb 2015

HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.

26 Feb 2015

UMass Amherst biologist partners with Chinese scientist to develop novel drug platform

Margaret Riley, an evolutionary biologist at the University of Massachusetts Amherst and pioneer in fighting antibiotic-resistant bacteria, announced this week that she is partnering with a Chinese scientist to develop a new drug platform, pheromonicins. The Chinese government is committing $400 million per year to support the newly created Pheromonicin Institute of Beijing.

26 Feb 2015

Next Generation News and Research

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

Covalon announces introduction of new MediClear product line to reduce surgical site infections

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

Medical Diagnostic Laboratories now offers new HPV tests

Pediatric Cancer Genome Project identifies genetic basis of three pediatric melanoma subtypes

New approach could dramatically increase survival rate of cancer patients

Oxytocin may be a potential therapeutic target for improving social function in psychiatric disorders

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Raising sale age for tobacco products to 21 may prevent adolescents from taking up smoking

VWR, New England Biolabs expand distribution agreement

Damon Runyon holds fourth annual Accelerating Cancer Cures Research Symposium

Chrono Therapeutics gets support to develop SmartStop device for smoking cessation

Tian Ge, Xi He collaborate to develop new mobile health management platform

Caltech researchers reveal new information that could help fight against hookworms

Scientists sequence genome of hookworm

Revolutionary Oral-B Bluetooth-enabled toothbrush, App launched at Mobile World Congress 2015

UC San Diego Health System's Movement Disorder Center joins NPF Center of Excellence network

Metrohm USA announces 2015 Young Chemist Award winner

HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

UMass Amherst biologist partners with Chinese scientist to develop novel drug platform

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News